Empirical Finance LLC raised its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 2.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 28,845 shares of the company’s stock after purchasing an additional 632 shares during the period. Empirical Finance LLC’s holdings in Colgate-Palmolive were worth $2,994,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. E Fund Management Hong Kong Co. Ltd. acquired a new position in shares of Colgate-Palmolive during the second quarter worth approximately $25,000. Continuum Advisory LLC raised its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Finally, Gradient Investments LLC boosted its position in shares of Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after buying an additional 400 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Trading Up 0.0 %
Shares of CL stock opened at $91.49 on Friday. The firm has a fifty day moving average of $99.94 and a 200-day moving average of $98.48. The stock has a market cap of $74.75 billion, a price-to-earnings ratio of 26.20, a P/E/G ratio of 3.25 and a beta of 0.42. Colgate-Palmolive has a 52-week low of $75.17 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.
Colgate-Palmolive Dividend Announcement
Wall Street Analyst Weigh In
CL has been the topic of several analyst reports. Jefferies Financial Group lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the company from $107.00 to $109.00 in a report on Monday, September 9th. Hsbc Global Res lowered Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. UBS Group boosted their target price on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $105.11.
Check Out Our Latest Stock Analysis on CL
Insider Buying and Selling at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Investing in Commodities: What Are They? How to Invest in Them
- Top-Performing Non-Leveraged ETFs This Year
- Want to Profit on the Downtrend? Downtrends, Explained.
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- EV Stocks and How to Profit from Them
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.